HomeADMA • NASDAQ
add
ADMA Biologics Inc
Previous close
$16.11
Day range
$15.73 - $16.29
Year range
$13.50 - $25.67
Market cap
3.84B USD
Avg Volume
3.39M
P/E ratio
19.06
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 121.98M | 13.80% |
Operating expense | 24.43M | 33.84% |
Net income | 34.22M | 6.73% |
Net profit margin | 28.05 | -6.22% |
Earnings per share | 0.14 | 11.54% |
EBITDA | 44.86M | 8.75% |
Effective tax rate | 14.66% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 90.28M | 2.31% |
Total assets | 558.38M | 48.35% |
Total liabilities | 160.06M | -14.92% |
Total equity | 398.32M | — |
Shares outstanding | 238.63M | — |
Price to book | 9.65 | — |
Return on assets | 20.02% | — |
Return on capital | 22.82% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 34.22M | 6.73% |
Cash from operations | 21.14M | -53.69% |
Cash from investing | -2.53M | -6.85% |
Cash from financing | 48.00K | 113.26% |
Net change in cash | 18.66M | -56.52% |
Free cash flow | 22.67M | -28.24% |
About
Founded
2004
Headquarters
Website
Employees
685
